Stocks and Investing Stocks and Investing
Wed, November 9, 2022
Tue, November 8, 2022

Matthew Harrison Maintained (BNTX) at Hold with Increased Target to $203 on, Nov 8th, 2022


Published on 2024-10-28 00:01:20 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $194 to $203 on, Nov 8th, 2022.

Matthew has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $132 on, Monday, October 24th, 2022


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $272 on, Wednesday, August 10th, 2022
  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Increased Target to $224 on, Friday, July 29th, 2022

Contributing Sources